Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder

Sponsor
Karolinska Institutet (Other)
Overall Status
Completed
CT.gov ID
NCT02864589
Collaborator
(none)
23
1
2
17
1.4

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the feasibility and acceptability of two different modalities of therapist-guided Internet-delivered behaviour therapy (IBT) for children and adolescents (7-17 years) with Tourette's Disorder (TD) or Persistent (Chronic) Motor or Vocal Tic Disorder (PTD).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Internet-delivered habit reversal training
  • Behavioral: Internet-delivered exposure and response prevention
N/A

Detailed Description

The primary objective of this study is to evaluate the feasibility and acceptability of two different modalities of therapist-guided Internet-delivered behaviour therapy (IBT) for children and adolescents (7-17 years) with Tourette's Disorder (TD) or Persistent (Chronic) Motor or Vocal Tic Disorder (PTD). The two modalities of IBT are habit reversal training (HRT) and exposure and response prevention (ERP). Secondary objectives are to evaluate whether IBT can decrease tic frequency and tic-related impairment, and, as both HRT and ERP have been proven efficacious in treating TD/PTD face-to-face, are any of the two treatments better suited to be delivered via the internet?

The design of the study is a randomized-controlled trial with 20 participants. Participants will be stratified by ADHD/ADD status.

The treatment duration is 10 weeks.

Feasibility and acceptability will be assumed if:
  • The two treatments can be successfully adapted to a therapist guided internet-delivered format (technical feasibility)

  • Patients/parents are willing to try the offered treatment modalities

  • Participants complete the active parts of the treatment

  • Referrers are open to the idea of internet-delivered treatment for TD or PTD

  • We can recruit sufficient numbers of patients for a fully powered efficacy trial

Regarding the secondary objective, the primary outcome is tic severity measured by the Yale Global Tic Severity Scale (YGTSS). Participants will be assessed directly after treatment (post), and at 3, 6 and 12 months after treatment. Assessments at post-treatment and 3 month follow up will be performed by assessors blinded to the treatment condition. After 3 months, we will naturalistically follow up patients up to 12 months after the end of treatment. Data collection will finish 12 months after treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
23 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder: A Feasibility Study
Study Start Date :
Aug 1, 2016
Actual Primary Completion Date :
Jan 1, 2018
Actual Study Completion Date :
Jan 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: I-HRT

Internet-delivered habit reversal training

Behavioral: Internet-delivered habit reversal training
The I-HRT group will receive a 10-week therapist-guided, parent-assisted, Internet-delivered behavioural treatment. The treatment is based on existing literature on habit reversal training (i.e. Woods, D.W. (2008). Managing Tourette syndrome: A behavioral intervention for children and adults therapist guide. OUP, USA.) with added interactive features as videos and illustrations. In short, the participants practice to become more aware of their tics and inhibit them by performing competing responses (movements). The treatment is therapist guided: the participants have regular (up to 5 days a week) contact with a personally assigned therapist via written text in the platform and occasionally via the telephone. The children and parents have separate logins and access partly different content.
Other Names:
  • HRT, HR
  • Experimental: I-ERP

    Internet-delivered exposure and response prevention

    Behavioral: Internet-delivered exposure and response prevention
    The I-ERP group receives a 10-week therapist-guided, parent-assisted, Internet-delivered behavioural treatment. The treatment is based on existing literature on exposure and response prevention (i.e. Verdellen, C. et al. (2011). Tics: Therapist manual & workbook for children. Boom, Amsterd.) with added interactive features as videos and illustrations. In short, the participants practice to suppress their tics for longer and longer times, at the same time as premonitory urges are intentionally provoked. The treatment is therapist-guided: the children and parents have regular (up to 5 days a week) contact with a personally assigned therapist via written text in the platform and occasionally via the telephone. The children and parents have separate logins and access partly different content.
    Other Names:
  • ERP
  • Outcome Measures

    Primary Outcome Measures

    1. Yale Global Tic Severity Scale (YGTSS) [Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up]

      Change in tic severity (motor and/or vocal tics) from week 0 (pre treatment) to week 10 (post treatment), 3 months follow up (after post treatment), 6 months follow up and 12 months follow up.

    Secondary Outcome Measures

    1. Clinical Global Impression - Severity (CGI-S) [Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up]

    2. Clinical Global Impression - Improvement (CGI-I) [Week 10; 3 months follow up; 6 months follow up; 12 months follow up]

    3. Children's Global Assessment Scale (C-GAS) [Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up]

    4. Parent Tic Questionnaire (PTQ) [Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up]

    5. Premonitory urge for Tics Scale (PUTS) [Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up]

    6. Gilles de la Tourette Syndrome Quality of Life Scale (GTS-QOL). [Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up]

    7. Obsessive-Compulsive Inventory - Child version (OCI-CV). [Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up]

    8. Children's Depression Inventory - Short version (CDI-S), with additional suicidality item [Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up]

    9. Mood and Feeling Questionnaire - Short version (MFQ) [Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up]

    10. Education, Work and Social Adjustment Scale - Child version (EWSAS-C) [Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up]

    11. Education, Work and Social Adjustment Scale - Parent version (EWSAS-P) [Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up]

    12. Treatment credibility scale [Week 3]

    13. Treatment satisfaction scale [Week 10]

    14. Safety Monitoring Uniform Report Form (SMURF) [Week 5; week 10]

    15. Internet Intervention Patient Adherence Scale (iiPAS) [Week 5; week 10]

    16. Parental strategy scale [Week 10]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    7 Years to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Fulfill DSM-5 diagnostic criteria for Tourette's Disorder or Persistent (Chronic) Motor or Vocal Tic Disorder (PTD).

    • 15 (TD) or >10 (PTD) on Yale Global Tic Severity Scale (Impairment not included).

    • Both child and parent are able to read and communicate in Swedish.

    • Regular access to a computer and the Internet.

    • Parent availability to support their child throughout the treatment.

    Exclusion Criteria:
    • Acute psychiatric problems such as severe depression, suicidal risk, substance abuse or another psychiatric disorder that could interfere with treatment.

    • Lifetime history of global learning disability, pervasive developmental disorder, psychosis, bipolar disorder or organic brain disorder.

    • Severe tics causing immediate risk to the patients or others and requiring urgent medical attention.

    • Previous behavioural therapy (HRT or ERP), minimum 8 sessions with qualified therapist, within the last 12 months prior to assessment.

    • Simultaneous psychological treatment for tic disorder.

    • Initiation or adjustment of any psychotropic medication for tics within the last 6 weeks prior to assessment.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 BUP CPF Stockholm Sweden 113 30

    Sponsors and Collaborators

    • Karolinska Institutet

    Investigators

    • Principal Investigator: David Mataix-Cols, Professor, Karolinska Institutet, Department of Clinical Neuroscience

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    David Mataix-Cols, Professor, Karolinska Institutet
    ClinicalTrials.gov Identifier:
    NCT02864589
    Other Study ID Numbers:
    • 2015/938-31/4
    First Posted:
    Aug 12, 2016
    Last Update Posted:
    Mar 6, 2018
    Last Verified:
    Mar 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by David Mataix-Cols, Professor, Karolinska Institutet
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 6, 2018